These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25792080)

  • 1. Postoperative intensity-modulated radiotherapy improved survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma.
    Zhang W; Liu X; Xiao Z; Zhang H; Chen D; Feng Q; Zhou Z; Lv J; Liang J; Hui Z; Wang L; Yin W; Cheng G; Sun K; Liu X; Fang D; He J
    Oncol Res Treat; 2015; 38(3):97-102. PubMed ID: 25792080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity modulated radiation therapy (IMRT) for sinonasal tumors: a single center long-term clinical analysis.
    Askoxylakis V; Hegenbarth P; Timke C; Saleh-Ebrahimi L; Debus J; Röder F; Huber PE
    Radiat Oncol; 2016 Feb; 11():17. PubMed ID: 26847089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical value of prophylactic radiotherapy after curative resection of esophageal carcinoma].
    Xiao Z; Yang Z; Liang J; Miao Y; Wang M; Yin W; Gu X; Zhang D; Zhang R; Wang L
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):608-11. PubMed ID: 12667338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.
    Lu JC; Tao H; Chen ZZ; Qian PD
    Dis Esophagus; 2009; 22(6):490-5. PubMed ID: 19191849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Liu J; Li J; Zhu K; Zheng X; Chen M; Chen M; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):671-7. PubMed ID: 23773390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the causes of failure after radical surgery in patients with
    Shen WB; Gao HM; Zhu SC; Li YM; Li SG; Xu JR
    World J Surg Oncol; 2017 Oct; 15(1):192. PubMed ID: 29070049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
    Guan X; Wang X; Liu Y; Hu C; Zhu G
    Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
    Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma.
    Zhang W; Liu X; Xiao Z; Wang L; Zhang H; Chen D; Zhou Z; Feng Q; Hui Z; Liang J; Yin W; He J
    Thorac Cancer; 2015 Sep; 6(5):597-604. PubMed ID: 26445608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
    Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
    Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma.
    Lu JC; Tao H; Zhang YQ; Zha WW; Qian PD; Li F; Xu KX
    Dis Esophagus; 2008; 21(6):502-7. PubMed ID: 18840135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
    Chang CL; Tsai HC; Lin WC; Chang JH; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
    Radiother Oncol; 2017 Oct; 125(1):73-79. PubMed ID: 28923576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
    Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma.
    Lu JC; Kong C; Tao H
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):710-4. PubMed ID: 20172661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.